Data gathered: September 18
Alternative Data for Exact Sciences
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 233 | Sign up | Sign up | Sign up | |
Sentiment | 100 | Sign up | Sign up | Sign up | |
Webpage traffic | 674,000 | Sign up | Sign up | Sign up | |
Employee Rating | 66 | Sign up | Sign up | Sign up | |
Google Trends | 67 | Sign up | Sign up | Sign up | |
Patents | 100 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 1,162 | Sign up | Sign up | Sign up | |
Facebook Followers | 10,036 | Sign up | Sign up | Sign up | |
Reddit Mentions | 1 | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 25 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 11,052 | Sign up | Sign up | Sign up | |
Twitter Followers | 6,725 | Sign up | Sign up | Sign up | |
Twitter Mentions | 823 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up | |
Business Outlook | 50 | Sign up | Sign up | Sign up | |
Linkedin Employees | 5,681 | Sign up | Sign up | Sign up |
About Exact Sciences
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers.
Price | $67.99 |
Target Price | Sign up |
Volume | 2,310,000 |
Market Cap | $12.8B |
Year Range | $41.33 - $74.26 |
Dividend Yield | 0% |
Industry | Biotechnology |
In the news
Quest Partners LLC Has $95,000 Holdings in Exact Sciences Co. (NASDAQ:EXAS)September 18 - ETF Daily News |
|
Investors Purchase High Volume of Call Options on Exact Sciences (NASDAQ:EXAS)September 17 - ETF Daily News |
|
Exact Sciences Co. (NASDAQ:EXAS) Position Lessened by Plato Investment Management LtdSeptember 17 - ETF Daily News |
|
Federated Hermes Inc. Sells 310,740 Shares of Exact Sciences Co. (NASDAQ:EXAS)September 17 - ETF Daily News |
|
Buy Rating Affirmed for Exact Sciences Following Promising CRC Screening Test DataSeptember 16 - TipRanks |
|
Buy Rating for Exact Sciences: Promising CRC Screening Test Outperforms with High Accuracy and Market PotentialSeptember 16 - TipRanks |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q2 '24 | 699M | 190M | 510M | -16M | 11M | -0.090 |
Q1 '24 | 630M | 170M | 459M | -110M | -84M | -0.600 |
Q4 '23 | 3.15B | 172M | 2.98B | -50M | -7.9M | -0.270 |
Q3 '23 | 620M | 169M | 452M | 790,000 | 25M | 0.004 |
Q2 '23 | 614M | 157M | 457M | -81M | -56M | -0.450 |
Insider Transactions View All
Herriott James filed to sell 9,866 shares at $60.2. May 2 '24 |
COWARD D SCOTT filed to sell 44,644 shares at $60.2. May 2 '24 |
Elliott Jeffrey Thomas filed to sell 11,795 shares at $60.2. May 2 '24 |
Condella Sarah filed to sell 72,611 shares at $60.2. May 2 '24 |
Baranick Brian filed to sell 13,279 shares at $60.2. May 2 '24 |
Similar companies
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
Joshua Gottheimer Democrat |
Jun 8, 24 | Sell | $1K - $15K |
Joshua Gottheimer Democrat |
Mar 7, 24 | Sell | $1K - $15K |
Kevin Hern Republican |
Feb 11, 24 | Sell | $1K - $15K |
Read more about Exact Sciences (EXAS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Exact Sciences?
The Market Cap of Exact Sciences is $12.8B.
What is the current stock price of Exact Sciences?
Currently, the price of one share of Exact Sciences stock is $67.99.
How can I analyze the EXAS stock price chart for investment decisions?
The EXAS stock price chart above provides a comprehensive visual representation of Exact Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Exact Sciences shares. Our platform offers an up-to-date EXAS stock price chart, along with technical data analysis and alternative data insights.
Does EXAS offer dividends to its shareholders?
As of our latest update, Exact Sciences (EXAS) does not offer dividends to its shareholders. Investors interested in Exact Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Exact Sciences?
Some of the similar stocks of Exact Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.